Mechanisms of Action Both peptides influence key metabolic pathways, including: Appetite regulation Satiety-signal intensity Feeding-drive behavior Gastric-emptying patterns Long-term energy balance Cagrilintide Mechanism Summary Broad activation across amylin and calcitonin receptor families Robust satiety effects due to multi-site signaling Strong fit for extended metabolic and appetite-regulation protocols Eloralintide Mechanism Summary Selective AMY1 receptor activation More focused signaling profile High-impact performance across long-term studies Side-by-Side Comparison Why These Peptides Are Frequently Compared Both peptides attract significant attention due to: Their strong influence on satiety pathways Clear reductions in feeding-drive behavior High stability in weekly-administered research models Their value in studying long-term metabolic outcomes Their differing receptor-activation patterns, allowing nuanced comparison Eloralintides high-dose results are particularly notable, while Cagrilintide remains a go-to option for stable, predictable satiety-pattern modeling

See the clinical trial data, side effects, dosing, and Canadian access options
The recommended dosage is 1-2 capsules daily, preferably in the morning on an empty stomach or with a light meal
Shao LX, Liao C, Gregg I, Davoudian PA, Savalia NK, Delagarza K, et al
Anti-inflammatory effect of amitriptyline in a rat model of acetic acid-induced colitis: the involvement of the TLR4/NF-kB signaling pathway